Clinical Trial Update: A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of ruxolitinib and abemaciclib for myelofibrosis (including myelofibrosis associated with polycythemia vera) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• Abemaciclib (abemaciclib)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myelofibrosis Due to and Following Polycythemia Vera | Phase 1 | Status: RECRUITING